Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:

18 Years and older (Adult, Older Adult)

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

Males or females

Control (Adult) group: aged between 18 and 65 years (inclusive)

Elderly group: aged > 65 years (includes subjects 1 day or more beyond the 65th birthday)

Able to give signed informed consent

BMI 27-45 kg/m2, inclusive 6. Eligible male and female subjects must agree not to participate in a conception process (i.e. active attempt to become pregnant or to impregnate, egg or sperm donation, in vitro fertilization).

Considered to be in stable health in the opinion of the Investigator

Exclusion Criteria:

Prior participation in any study of lorcaserin.

Clinically significant new illness in the 1 month before screening

Not suitable to participate in the study in the opinion of the Investigator including an existing physical or mental condition that prevents compliance with the protocol